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increasing their investment in VAWG prevention programs, yet clear 
guidelines to assess the “value for money” of these interventions are 
lacking. Improved costing and economic evaluation of VAWG prevention 
can support programming through supporting priority setting, justifying 
investment, and planning the financing of VAWG prevention services. This 
article sets out a standardized methodology for the economic evaluation of 
complex, that is, multicomponent and/or multiplatform, programs designed 
to prevent VAWG in low- and middle-income countries (LMICs). It outlines 
an approach that can be used alongside the most recent guidance for the 
economic evaluation of public health interventions in LMICs. It defines 
standardized methods of data collection and analysis, outcomes, and unit 
costs (i.e., average costs per person reached, output or service delivered), 
and provides guidance to investigate the uncertainty in cost-effectiveness 
estimates and report results. The costing approach has been developed and 
piloted as part of the “What Works to Prevent Violence Against Women 
and Girls?” (What Works?) program in five countries. This article and its 
supplementary material can be used by both economists and non-economists 
to contribute to the generation of new cost-effectiveness data on VAWG 
prevention, and ultimately improve the allocative efficiency and financing 
across VAWG programs.
Keywords
intimate partner violence, violence against women and girls, women’s 
empowerment, community mobilization, costing, cost-effectiveness, 
outcome measurement
Introduction
Globally, 35% of women have experienced intimate partner violence (IPV) 
(Devries et al., 2013). Violence against women and girls (VAWG) has impor-
tant social, economic, and public health impacts, in addition to being a human 
rights concern. Exposure to IPV is associated with an elevated risk of a num-
ber of adverse health outcomes, such as HIV, induced abortion, and preterm 
birth (World Health Organization [WHO], 2013), as well as a number of 
adverse mental health outcomes (Ferrari et al., 2016; WHO, 2013). Given the 
scale of the problem, governments and international donors are allocating 
increasing resources to address VAWG, particularly IPV. The United 
Kingdom and the World Bank alone have invested more than US$400 million 
in programs for, and research on, the prevention of VAWG and support to 
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survivors in low- and middle-income countries (LMICs; Global Gender-
Based Violence Task Force, 2017), and the WHO has issued guidelines on 
violence prevention programming for policy makers and planners (WHO, 
2010).
The scale of the investment and policy focus on VAWG warrants an 
increased interest in assessing the value for money of VAWG interventions. 
Evidence on the economic value of violence prevention and development 
programming is, however, scarce. In addition, assessments of VAWG are 
methodologically challenging for three reasons. First, it is difficult to account 
for and value the diverse outcomes of VAWG prevention in areas such as 
health, education, work, social networks, and access to financial resources. 
Second, cost estimates are currently only available from small research proj-
ects, which may not be representative of costs of implementing at scale. 
Third, VAWG prevention delivery processes vary by context, and culturally 
specific gender norms, limiting the generalizability of costs and economic 
evaluation.
We outline a standardized methodology for the economic evaluation of 
complex VAWG prevention interventions. We developed this methodology by 
adapting current general guidance on economic evaluation and costing in 
global health (Neumann, Sanders, Russell, Siegel, & Ganiats, 2016; Vassall 
et al., 2017 [https://ghcosting.org/pages/standards/reference_case]; Wilkinson 
et al., 2016) to the characteristics of VAWG prevention programming. Analysts 
intending to apply our guidelines should be familiar with the general guidance 
too. Our aim is to provide further specification around their specific applica-
tion to VAWG prevention.
“What Works to Prevent Violence Against Women and Girls?” (What 
Works?) is a multicountry, multiyear research and innovation program that 
tested the effectiveness and cost-effectiveness of VAWG prevention pro-
grams in LMICs. It is funded by the United Kingdom’s Department for 
International Development (DfID) and it set up an international network of 
implementers, VAWG prevention professionals, and researchers who co-
created and evaluated these interventions. The economic evaluation compo-
nent was tasked with determining the value for money of six interventions 
implemented alongside randomized controlled trials. The interventions were 
implemented in six different countries, five in sub-Saharan Africa, and one 
in South Asia, and across different platforms: schools, villages/communi-
ties, and adult small-group learning settings. We developed a standardized 
economic evaluation methodology to improve transparency in value for 
money estimates of VAWG interventions, as well as their comparability, rep-
licability, and generalizability (Evans & Popova, 2016), for What Works? 
and beyond.
4 Journal of Interpersonal Violence 00(0)
Our structure and approach to economic evaluation methods are in line 
with the Reference Case approach outlined in the International Decision 
Support Initiative (iDSI) guidelines (2014), which remain largely within the 
extra-welfarist framework (Brouwer, Culyer, van Exel, & Rutten, 2008) that 
is prevalent in economic evaluation in the health sector (Neumann et al., 
2016; Vassall et al., 2017; Wilkinson et al., 2016). We do not state here 
whether a specific method of economic evaluation (cost-effectiveness, cost-
utility, cost-consequence, or benefit–cost analysis) should be adopted, 
because this decision will also depend on the specific problem analysts are 
faced with, as well as on data availability. For methods related to costing, we 
also referred to the Global Health Costing Consortium (GHCC) Reference 
Case (Vassall et al., 2017). Both sets of guidelines are designed for global 
health and are consistent with the Second U.S. Panel on Cost-Effectiveness 
in Health and Medicine (Neumann et al., 2016) and the Consolidated Health 
Economic Evaluation Reporting Standards (CHEERS) guidelines (Husereau 
et al., 2013).
We also referred to the U.K. DfID Value for Money (VfM) framework for 
the assessment of the economy, efficiency, effectiveness, and equity of its 
programs (DfID, 2011). Specifically, we state how our recommendations 
relate to DfID’s framework and its implementation. The article begins by 
explaining and discussing the challenges in identifying, measuring, and valu-
ing resources and outcomes. We then list the issues to consider in analysis. 
We summarize our recommendations for each of the iDSI and GHCC prin-
ciples in Tables A1 and A2 in the appendix. Copies of the manual and tools to 
accompany the guidance outlined in this article are available on the What 
Works? website as a project resource.1
The Decision Problem
The basis for any economic evaluation of an intervention is the “decision 
problem” (Vassall et al., 2017 [https://ghcosting.org/pages/standards/refer-
ence_case]). The decision problem outlines the investment choice and can be 
defined by target Population, Intervention, Comparator, and Outcome (PICO) 
to be achieved in a PICO statement (see Figure 1 for two examples; 
Richardson, Wilson, Nishikawa, & Hayward, 1995).
Population
The typical target populations of VAWG prevention are women and girls. 
However, due to the complexity of VAWG, costs and outcomes fall on other 
populations (externalities) and need to be considered for decision makers 
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interested in broader social welfare. For example, male perpetrators of vio-
lence may also benefit from decreased use of violence. Children may be 
adversely affected by mothers’ exposure to violence (Hardt et al., 2015; 
Smith-Marek et al., 2015) and thus gain from a reduction in violence. 
Women’s improved access to economic resources may also improve child 
health and educational outcomes (Duflo, 2003). More generally, changing 
social norms and gender attitudes through targeting entire communities may 
result in spillover benefits to those directly and indirectly affected by vio-
lence (Stern, Heise, & McLean, 2017).
Intervention
Analysts should describe the intervention, including all activities required for 
its development and implementation. Broadly, VAWG interventions can be 
classified as workshop-based interventions (for individuals, families, or cou-
ples), economic empowerment interventions (with or without gender-
empowerment components), school interventions delivered to classes, 
psychotherapeutic interventions including self-defense, and gender attitudes 
and social norms change interventions delivered to communities (often mul-
tiple components, for example, including workshops, community action 
teams, street theater, murals, and community radio). Workshops, gender 
empowerment, and programs delivered to classes are often administered over 
a limited number of small-group sessions (Gibbs et al., 2017; Iyengar & 
Figure 1. PICO statements from two What Works? interventions.
Note. PICO = Population, Intervention, Comparator, and Outcomes; What Works? = “What 
Works to Prevent Violence Against Women and Girls?”
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Ferrari, 2011). Trained facilitators deliver a curriculum, which includes ses-
sions on gender, power, and violence; teaching a mixture of vocational and 
communication skills; supporting help-seeking or providing support; and 
skills of critical reflection. The assumption is that increased information on 
harmful norms and behaviors and an expanded skillset for challenging these 
will reduce exposure to, and perpetration of, VAWG. Community-based 
interventions aimed at reducing VAWG have also shown encouraging impact 
(Abramsky et al., 2014). They typically entail the identification and training 
of local volunteers. Some community-based schemes first raise VAWG 
awareness and then build positive concepts and practices of power in the pool 
of potential recruits. In turn, the most motivated recipients become commu-
nity mobilizers and administer the intervention to the rest of the community 
(Pronyk et al., 2006; Stern & Niyibizi, 2018). Some VAWG prevention inter-
ventions are implemented using existing services (such as community financ-
ing schemes or schools).
Strengthening local services/platforms at times precedes the intervention 
(Pronyk et al., 2002; Stern & Niyibizi, 2018) and may incur costs. Analysts 
should clearly describe the platform, in terms of the existing services deliv-
ered, the scale of operation, and where services are delivered jointly. 
Understanding the platform is required to correctly identify the incremental 
costs of the investment and generalize results across settings. Specifically, the 
platform will influence costs and/or outcomes, through synergistic benefits, 
or economies of scope. Economies of scope occur when costs are reduced 
through improved efficiency as a result of joint production; for example, 
where the cost of a combined life skills and microfinance intervention is less 
than the cost of providing these two interventions separately.
It is also critical to clearly describe any activities required to start the 
VAWG intervention. Typical start-up activities for complex interventions 
include curriculum development, curriculum adaptation, frontline workers’ 
training, and obtaining permission to operate locally. Where feasible, total 
costs of development should be estimated and included in cost-effectiveness 
estimates. However, if the interventions were developed over a long period of 
time through iterative processes, more than five years prior to the study, costs 
may not be properly documented. This makes it particularly challenging to 
identify all relevant resources, increasing the likelihood of inaccurate costing 
and reducing comparability if costs can be determined for some interventions 
but not for others. In such cases, we recommend reporting total development 
costs separately, where these can be determined, and refraining from includ-
ing them in the cost-effectiveness estimates. Where a program is scaling up, 
a clear description of any activities to scale up from the research setting stage 
is necessary (Evans & Popova, 2016).
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Comparator
In assessing cost-effectiveness, analysts must establish incremental costs and 
benefits compared with the status quo (i.e., usual care or “do nothing”). In 
some cases, different investment options may also be compared, as they will 
be part of the “choice set” of interventions the decision maker is deliberating. 
For interventions introduced as add-ons to existing programs (Gupta et al., 
2013; Iyengar & Ferrari, 2011; Pronyk et al., 2006), the existing program is 
considered the usual care (control) scenario. Particularly where this may be 
required to enable scale-up, a do-nothing comparator and the cost of strength-
ening the status quo should be included.
Relevant comparators that may be accessed by the target population to 
improve their outcomes should be included, even if not directly connected 
with the specific Randomised Controlled rial (RCT) or evaluation. Particular 
difficulties in assessing the status quo do not justify its exclusion from analy-
sis (Sculpher, Claxton, Drummond, & McCabe, 2006). For complex, multi-
component programs already administered at scale and not evaluated with 
RCTs, analysts may exploit gradual rollout or other econometric or modeling 
techniques to characterize the comparators or create synthetic controls, rather 
than exclude the status quo (Jones, 2015).
Outcomes
The primary outcomes typically reported in the evaluation of VAWG preven-
tion are the number of cases of IPV and/or disability-adjusted life years 
(DALYs) averted (Jan et al., 2011; Michaels-Igbokwe et al., 2016). However, 
these may only be a partial measure of impact: DALYs capture a subset of 
IPV health sequelae, and many interventions (particularly those delivered on 
joint platforms) are likely to affect outcomes beyond VAWG. In addition, 
outcomes may interact with each other. Therefore, these outcomes may not 
capture the full direct impact of interventions and their broader societal 
impact (Neumann et al., 2016).
To address this complexity pragmatically, we recommend analysts first 
list all relevant outcomes. This “impact inventory” should include all out-
comes posited in the intervention’s theory of change (Neumann et al., 2016, 
p. 101), including impacts that will materialize at a later stage, beyond the 
immediate effects of the intervention, which may require modeling. Some 
of these impacts will be captured in the secondary endpoints in trials and 
evaluations, and will generally be included in the intervention’s theory of 
change. Testing of multiple outcomes in economic evaluation is handled 
within a Bayesian framework (Briggs, 1999), which naturally accounts for 
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simultaneous tests (Scott & Berger, 2006). Where there are sectoral deci-
sion makers, outcomes should then be assigned to the relevant sector of the 
economy more likely to benefit from them (Jones, 2015; Remme, Martinez-
Alvarez, & Vassall, 2017) or a cost–benefit analysis can be conducted. A 
list of suggested outcomes, common to the prevention of VAWG, is shown 
in Table 1.
Measuring exposure to or perpetration of VAWG. At a minimum, outcomes 
should be reported in natural units, including cases of physical and/or sexual 
VAWG (experienced or perpetrated) averted. This allows for some compara-
bility with preexisting studies. In addition, analysts should specify the type of 
VAWG the intervention is tackling: For example, if the intervention tackles 
IPV, they will specify “cases of IPV exposure (and/or perpetration) averted.” 
The time period of the outcome (see below) should also be included in the 
outcome measure, so that, “IPV cases averted in the past year,” is reported as, 
“IPV-free person years.” In general, past year is an appropriate time frame, 
because prevention interventions may not prevent further exposure to vio-
lence and measuring lifetime exposure would mean that prevention efforts 
would only be counted among women and girls who have never experienced 
violence. Furthermore, the use of “past year” aims to strike a balance between 
recall bias and rarity of the event (Garcia-Moreno, Jansen, Ellsberg, Heise, & 
Watts, 2006). Finally, a measure of frequency of exposure to violence over 
the past year permits the estimation of reductions in exposure, even in women 
who were not free of violence in the previous year, and some studies report 
costs per past year incident averted (Greco et al., 2018). However, this may 
be problematic in settings with high rates of violence, for which shorter time 
periods of reference may be preferred, though this will reduce comparability 
with studies that measure IPV exposure over the past year.
Health outcomes. Outcomes should be converted to general comparable met-
rics where feasible, for potential payers in different sectors. For example, if 
the health sector is likely to be a payer, then estimates of DALYs averted 
should be derived. Key health sequelae that could be considered will vary 
according to the age group and social context of the intervention beneficia-
ries, but mental health measures such as symptoms of post-traumatic stress 
disorder, anxiety, depression, suicidality, and substance abuse should be 
included (Devries et al., 2013), as well as injuries. In some populations, sex-
ual and reproductive health outcomes such as preterm births and miscar-
riages, unwanted pregnancies averted, number of sexual partners, engagement 
in transactional sex or sex work, condom use, sexually transmitted infections, 
HIV, or HSV2 (herpes simplex virus type 2, which causes genital herpes) 
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Table 1. List of Recommended Outcomes for the Economic Evaluation of 
Violence Prevention.
Domain Suggested Outcomes
Partner violence Self-reported past year physical and/or sexual partner violence, 
experienced or perpetrated
Self-reported past year emotional partner violence, 
experienced or perpetrated
Self-reported past year economic partner violence, experienced 
or perpetrated
Self-reported past year controlling behavior, experienced or 
perpetrated
Other violence Violence from/to non-partner (both men and women)
Child exposure to intimate partner violence
Child abuse
Health Anxiety/depression
Post-traumatic stress
Suicidality
Hazardous alcohol and/or drug use
Physical injuries
Preterm and/or low birthweight 
offspring
Miscarriages or abortions
Femicide
HIV/STIs
Sexual risk taking
Nutrition
DALYs
QALYs
Women’s participation 
in health-related 
household decisions
Gender norms 
and roles
Equitable gender attitudes
Women’s participation in non-health-related household 
decisions
Economic 
and socio-
psychological
Individuals’ employment outside the 
household
Individuals’ income
Individuals’ ability to retain control 
over their own income
Individuals’ consumption
Savings behavior and time 
preference
Poverty
Criminality due to lack of money
School performance
Absence from school
School dropout 
(including pregnancy-
related)
Well-being (life 
satisfaction and 
flourishing)
Locus of control
Self-esteem/Self-efficacy
Agency
Institutions Proportion of victims receiving formal or informal support
Improved institutional response to cases of VAWG reported
Equal opportunities in the workforce
Note. STIs = sexually transmitted infections; DALYs = disability-adjusted life years;  
QALYs = quality-adjusted life years; VAWG = violence against women and girls.
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acquisition would be relevant. DALYs can be computed directly on health 
outcomes using the latest methodological recommendations (Lim et al., 
2012; Murray et al., 2012; Salomon et al., 2015), or indirectly with DALY 
weights attributed to IPV exposure (Lim et al., 2012; Murray et al., 2012; 
Watts & Cairncross, 2012).
Non-health outcomes. Furthermore, non-health outcomes such as educational 
attainment among teenagers, participation in household decision-making, 
controlling behaviors, and social norms on gender relations and the accept-
ability of violence are associated with VAWG (Fulu & Miedema, 2015; 
Heise, 1998). They are typically included in theories of change around 
VAWG, and should therefore be included in the impact inventory, and 
reported in a cost-consequence analysis at a minimum (Neumann et al., 
2016). The set of non-health outcomes will vary across interventions and 
contexts. For example, an intervention to prevent sexual assault among young 
teenagers, such as the IMpower intervention in Kenya, could measure expo-
sure to sexual assault as its main outcome, as well as school attendance or 
drop-out rates, and school grades or children’s cognitive ability as secondary 
outcomes. In contrast, an intervention designed to prevent IPV in couples that 
are members of microfinance associations, such as the Indashyikirwa cou-
ples’ intervention in Rwanda, will have IPV cases averted as a main outcome 
and may have participation in household decision-making, social attitudes 
toward IPV and gender relations, and socially harmful behaviors, such as 
harmful alcohol and drug consumption, as secondary outcomes.
Outcomes should be converted to general measures where feasible, for 
potential payers in different sectors. For example, a general measure of edu-
cation, such as attainment on standard tests or of high school diploma, for the 
education sector, or net income for the labor sector, or DALYs/QALYs for the 
health sector.
Recommendations on outcomes reporting. Listing outcomes may help sectoral 
payers (i.e., policy makers who operate in specific sectors and may commis-
sion, and pay for, the intervention to be scaled up) but does not account for 
the relative value of those outcomes or interaction between outcomes. It also 
may not fully inform payers interested in overall economic welfare. Analysts 
may therefore wish to consider composite outcomes, including benefit–cost 
ratios (equity or non-equity adjusted) and/or using measures of economic 
well-being. There are several approaches for this, but there has only been 
limited application of these measures to VAWG prevention to date. One “first 
step” option is that outcomes could be used to construct “empowerment” 
indices (Greco, Lorgelly, & Yamabhai, 2016). Empowerment indices require 
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extensive preparation to ensure that domains and weights used in computing 
the index are locally determined and relevant, while also capturing underly-
ing dimensions of subjective/psychological well-being (Ferrari, 2016).
Another simple approach, which is currently being applied to VAWG 
evaluation in What Works?, is to collect measures of global well-being to 
proxy participants’ utility. Measures of flourishing (Diener, 2009) capture a 
psychological construct of empowerment likely to be affected by complex 
interventions (Ferrari,2016). Measures of life and health satisfaction are also 
widely used. These measures partly overlap with health-related quality-of-
life measures (Brazier, Ratcliffe, Saloman, & Tsuchiya, 2017; Mukuria & 
Brazier, 2013). One option being investigated by several research groups is to 
use these measures to inform a benefit–cost analysis by determining the nec-
essary monetary compensation to keep an individual at the level of well-
being corresponding to their permanent income, given their health condition 
(Jones, 2015; Neumann et al., 2016; Powdthavee & Van Den Berg, 2011; 
Sunstein, 2016). Such estimates could also be complemented by modeling of 
costs and benefits to provide more comprehensive estimates of the benefits 
and costs of these interventions to society.
Perspective
In some circumstances, VAWG prevention interventions require considerable 
community resourcing. Therefore, a provider perspective, including the costs 
to the grassroots nongovernmental organization (NGO), the local public 
payer if public services are used by study participants, and any donor or vol-
unteer contributions, may be appropriate in most cases. Where clients or tar-
get populations incur costs to access services, we also recommend a societal 
perspective (Sanders et al., 2016; Vassall et al., 2017). A societal perspective 
includes clients’ and households’ costs, including lost productivity from time 
spent off work due to illness. In some cases, a societal perspective will also 
include sectors which incur external costs such as police and justice system 
costs.
Time Horizon
In line with iDSI Principle 6, the time horizon for the evaluation should cap-
ture all costs and effects. A lifetime horizon is recommended. Only where 
shorter time frame is demonstrably adequate, can there be an exception. Two 
possible reasons would justify a shorter time frame. First, program benefits 
are only experienced during the intervention. However, VAWG prevention 
aims for sustainable changes in behavior. Therefore, analysts must use 
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available evidence to inform decisions about the likely persistence of this 
longer term effect. Consideration should also be given to the expected dura-
tion of health effects to determine total DALYs. We recommend a minimum 
scenario with no effect duration beyond the intervention, and a scenario 
where duration of effect goes beyond the intervention period, supported by an 
adequate rationale. In such cases, decision makers should be provided with at 
least a summary of the evidence on longer term impact of VAWG prevention 
(Lim et al., 2012; WHO, 2013), even if not directly estimated in their setting 
(Jones, 2015).
Resource Use and Costing
VAWG interventions are varied and evolving, and policy makers will need to 
adapt estimates to different settings or as interventions are implemented. 
Detailed reporting of inputs, allocation criteria, and prices will help users of 
costs to adjust costs with changing prices and service delivery models and 
identify scope for improving efficiency with scale-up.
Type of Unit Cost
An economic cost2 is required for the economic evaluation, but financial 
costs, that is, costs that are effectively incurred by an organization, such as 
expenses or salaries, can provide useful information for decision makers 
assessing budget impact. In many cases, the decision maker is trying to estab-
lish whether to implement VAWG prevention (rather than invest in research) 
so analysts should estimate “real-world” costs that reflect the reality of 
implementation. Such costs can include incremental costs of removing con-
straints on implementation, for example, constraints to recruitment rates 
imposed by staff numbers (Jan et al., 2011) and staff turnover (Ferrari, Feder, 
Bailey, Peters, & Hollinghurst, in press).
Scope of Inputs
Many VAWG interventions add to existing services, so analysts will need to 
determine which costs are incremental. It may be necessary to consider econo-
mies of scope: Analysts should empirically estimate the cost of the platform 
(e.g., microfinance) service provision in both the intervention and the compara-
tor, and the incremental cost obtained from their difference. If this is not feasi-
ble, incremental intervention costs should be measured using a transparent 
allocation procedure for joint costs; determined by the measurement of actual 
resource use (e.g., human resources should be allocated according to time spent).
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A challenge for analysts involved in costing VAWG interventions is likely 
to be how to cost interventions that employ spare capacity in existing plat-
forms. Even though this use of spare capacity may have no immediate oppor-
tunity cost, over time there may be one. For example, in a school-based 
intervention, VAWG programming may use teacher time. The time spent on 
the intervention by teachers with spare capacity may have neither immediate 
nor short-term economic costs. However, in the longer run, there may be an 
opportunity cost, in that the teacher’s time could be used to support students 
in other ways. Moreover, as a program is scaled up, spare capacity may not 
be present (Meyer-Rath et al., 2012). This information is likely to be of use to 
decision makers (Jones, 2015). We recommend including the cost of such 
spare capacity in a sensitivity analysis and discussing the extent to which 
excess capacity was drawn upon in the intervention. For example, in their 
economic evaluation of the Good School Toolkit in Uganda, Greco et al. 
(2018) provide evidence that teaching the Toolkit does not displace teachers’ 
time, and report unit costs that may be used for further analysis.
Methods for Estimating Resource Use
As VAWG prevention is in its early stages and interventions are not standard-
ized, we recommend a micro-costing methodology (i.e., measuring the inputs 
used to produce a given output) to provide the level of detail requested by 
GHCC Principle 7 (Table A2). We recommend micro-costing even where 
some standardized or reference costs (average costs of services computed 
according to standard methodologies such as in the United Kingdom; Curtis 
& Burns, 2017) may be available. We recommend distinguishing between 
bottom-up (where all resources are observed and added up) and top-down 
estimates (where aggregate costs are used and allocated to different activities 
and interventions). To aid the costing of VAWG prevention and women's 
empowerment interventions, we have developed an Excel™ costing tool and 
data collection instruments for public use (see https://bit.ly/2vKaGZZ). The 
tool must be adapted for each intervention and setting but can serve as a start-
ing point to identify all inputs, allocation methods, and methods for calculat-
ing unit costs.
Units for the Calculation of Unit Costs
We recommend computing costs for the units listed in Table 2, developed 
using the GHCC framework. Providing estimates of costs of these standard-
ized units allows for comparability across different interventions and sites.
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This framework identifies above-site, direct, and ancillary unit costs of ser-
vice delivery, and aggregates them as illustrated in Figure 2. Direct service 
units should be further defined in each setting to capture the outputs that char-
acterize most interventions: teaching delivered to classes, counseling sessions, 
radio episodes, or community-based activities for the delivery phase.
Sampling
VAWG interventions are delivered across a range of settings. In some cases, it 
may be useful to generate nationally representative cost estimates. In others, a 
focus on specific populations, settings, or interventions may be more appropriate 
(Evans & Popova, 2016). Sampling design should reflect these different purposes 
(GHCC Principle 8; Table A2). Costing may require a two-stage sampling of 
communities and within them specific sites or groups (such as the sampling of 
community health workers [CHWs]). The sampling frame should contain infor-
mation on the key cost drivers of VAWG service delivery, such as amount of 
services delivered per site. If the program is large enough (n > 6 sites per stratum 
and N > 5 strata), analysts could draw a random sample of delivery sites stratified 
by the relevant cost driver(s); otherwise, they should sample sites purposively.
Shadow Prices and Valuation
GHCC Principle 14 states that all shadow prices, that is, “the true social 
opportunity cost[s]” of inputs (McIntosh, 2010, p. 40), be labeled as such and 
Figure 2. Intervention unit costs (UCs) and their components.
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reported alongside the source. The successful piloting and sustainability of 
scale-up for some VAWG prevention interventions will depend on volunteer 
labor (Kasteng, Settumba, Källander, Vassall, & inSCALE Study Group, 
2016), whose time should be valued appropriately (Jan, Pronyk, & Kim, 
2008; Kasteng et al., 2016; Michaels-Igbokwe et al., 2016). Once all tasks in 
a volunteer’s working day have been identified (e.g., life skills session; 
administrative report writing, supervision of volunteers), we recommend 
using replacement price, pricing volunteers’ time at the cost of their closest 
substitute (e.g., CHW, administrator, CHW supervisor). However, in some 
cases, replacement prices do not fully represent the cost of foregoing the 
volunteer’s time on the next best alternative. If programs are scaled up, the 
increasing demand on community time will mean that opportunity costs may 
rise, as more productive members of the community are involved.
Uncertainty
We address methodological uncertainty by providing these standardized 
guidelines (Briggs et al., 2012). We also recommend exploring structural 
uncertainty, as a minimum. This derives from model assumptions, such as 
discount factor and conversion rates (Dhaliwal, Duflo, Glennerster, & 
Tulloch, 2013; Wordsworth & Ludbrook, 2005). We also recommend that, 
where feasible, uncertainty around economies of scale and scope be exam-
ined, particularly when using research setting costs to inform investments in 
VAWG scale-up (Evans & Popova, 2016). Where empirical analysis is unfea-
sible, these investigations will include scenario analysis based on the estima-
tion of a cost function to obtain the marginal cost for a given scale or scope 
of an intervention (Neumann et al., 2016). We recommend presenting a range 
of scenario analyses that consider both different levels of spare capacity and 
changes in costs due to different levels of fixed costs across locations as a 
program expands. If a program is anticipated to have high levels of coverage, 
then diseconomies of scale, that is, increasing unit costs compared with a 
situation with lower coverage, should also be explored (Briggs et al., 2012). 
Table A3 in the appendix reports the sensitivity analyses we recommend.
Conclusion
Donors are increasing resources targeting the prevention of VAWG in LMICs, 
both by implementing prevention-focused programs and adding VAWG pre-
vention to other interventions. In the face of this increased investment, tools 
for evidence-based resource allocation should be upgraded.
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This article lays out a standardized methodology for the economic evalu-
ation of VAWG prevention interventions, which is also more widely appli-
cable to complex empowerment and behavioral interventions. Such 
interventions are complex, with multiple components and administered 
across many service platforms and settings. This poses challenges to the esti-
mation of comparable costs and means that guidance may change over time. 
We outline criteria for the identification of unit costs that capture core activi-
ties likely to be common across interventions. We recommend unit costs for 
reporting (see Table 2), as well as the measurement and valuation of resource 
use to improve the comparability of intervention costs across settings and 
provide tools to support data collection.
In addition, our standard methodology accounts for the diversity of pre-
vention programming recipients. We identify outcomes relevant to women, 
men, children, and adolescents. The acknowledgment of these distinct groups 
of recipients, and the use of subgroup-specific outcomes, alongside common 
outcomes, will yield insights into any heterogeneity in programming cost-
effectiveness. This will contribute valuable information for decision-making 
around the financing of VAWG prevention services that take intersectionality 
into account.
We do not provide guidance on how to incorporate the availability of 
health or social-support systems that provide the context for the implementa-
tion. Collecting these data would provide information on the impact the inter-
vention may have on downstream services (e.g., a VAWG referral system 
beyond the intervention being studied, or reduced use of health services due 
to reduced exposure to VAWG) and help analysts quantify the wider costs or 
cost savings that the intervention is likely to determine for other services. We 
think this would be a fruitful area of investigation for the future and encour-
age efforts in this direction. Many VAWG prevention interventions rely on 
lay frontline workers. This is especially the case for community-based mobi-
lization interventions. In such cases, little is known about what incentives 
these workers may require keeping delivering the intervention beyond the 
lifetime of the initial phase, thereby guaranteeing the sustainability of the 
intervention. Understanding their motivation for this type of work, and the 
incentive structure they respond to, is key to guaranteeing the sustainability 
of community-based interventions beyond VAWG prevention and beyond the 
health sector. It needs to be better understood to estimate the costs of these 
interventions. Finally, there remain challenges in identifying standard out-
comes that may be compared across interventions, within the health sector 
and beyond, including as lagged secondary effects, and understanding the 
duration of the effect.
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Our recommendations include the estimation of standardized measures of 
VAWG and of a synthetic measure of health impact in the DALY. These mea-
sures are not comprehensive and other measures can also be used, but as 
standard minimum data set, they can increase comparability with other 
VAWG and public health interventions and yield transparent modeling 
results. We recommend the identification of an “impact inventory,” whose 
components may be summarized in a multidimensional index, as a measure 
of impact and of synthetic measures of well-being to capture intervention 
impact on individuals’ utility. Future research should explore the links 
between health and non-health dimensions (economic and social outcomes) 
and violence, to produce estimates for use in the modeling of prevention cost-
effectiveness and benefit. Further work is also needed to map and measure all 
relevant VAWG health sequelae in longitudinal data sets to capture the full 
long-term health impact of VAWG and, consequently, the health benefits of 
prevention.
Analysts and practitioners may encounter some obstacles in the imple-
mentation of this methodology. First, it is possible that the data are not avail-
able at the level of detail required for a micro-costing or impact measurement 
in line with our recommendations. In such cases, for costing, analysts should 
adopt a top-down gross costing approach and include the best available out-
comes for impact measuring, acknowledging in both instances that they are 
deviating from the preferred recommendation.
Improved costing and impact measurement to account for the data needs 
of economic evaluations will be a critical part of the effort to scale-up and 
mainstream VAWG prevention. We hope that these methods provide a sound 
and comparable starting point to this effort.
Appendix
Violence Against Women and Girls (VAWG) Guidelines in 
Context
Table A1. iDSI Reference Case and VAWG guidelines.
iDSI Statements of Principle
(Adapted with permission from: 
https://www.idsihealth.org/resources/
summary-table/) VAWG Guidelines
 1.  Clear and transparent 
communication to enable the 
decision maker(s) to interpret 
methods and results (also in GHCC 
1, 2, and 17).
Adherence to these guidelines is recommended, and reasons 
for deviation should be provided.
(continued)
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iDSI Statements of Principle
(Adapted with permission from: 
https://www.idsihealth.org/resources/
summary-table/) VAWG Guidelines
 2.  Comparator(s) to accurately 
reflect the decision problem (see 
also GHCC 1).
These guidelines describe cost data collection and analysis 
methods for the purpose of economic evaluation of VAWG 
prevention interventions, and have wider applicability to 
behavioral change and development interventions. A PICO 
statement is used to describe the intervention. This identifies 
all key elements of the decision problem and excludes any 
non-pertinent elements (also see “comparator” section)
 3.  Consider all available evidence 
relevant to the decision problem.
Include all evidence from the literature that may be relevant to 
the decision problem. Where this information is not available, 
direct communication with policy makers may provide the 
required information.
 4.  Health outcome measure is 
(a) appropriate to the decision 
problem, capturing positive and 
negative effects on length and 
quality of life, and (b) generalizable 
across disease states (see also 
GHCC 4).
Intervention outcomes should encompass (a) an effect measure 
in natural units—For example, years free of VAWG; (b) a 
health outcome measure, namely, DALYs; (c) psychological 
and socioeconomic measures capturing outcomes likely to be 
affected by the intervention; and (d) measures of well-being, 
to capture overall well-being impact and as a proxy for the 
utility individuals derived from the intervention.
 5.  All differences in the expected 
resource use and costs of 
delivery between intervention 
and comparator should be 
incorporated into the evaluation.
Studies should implement a bottom-up approach based 
on micro-costing for direct costs. Deviation from this 
recommendation is acceptable for management costs, which 
could be computed using a top-down approach. Research 
costs are recorded and reported but excluded from cost-
effectiveness estimates. Data are to be collected with a view 
to informing scalability analyses.
 6.  Time horizon should be of 
sufficient length to capture all 
costs and effects relevant to the 
decision problem. An appropriate 
discount rate should be used 
to discount cost and effects to 
present values (see also GHCC 5).
The time horizon covers intervention adaptation and setup 
(i.e., training of local staff and community entry), in addition 
to implementation. It also includes intervention development 
where interventions are new and have never been tested 
for cost-effectiveness. Costs should be reported separately 
for each of these phases. Total development costs are to 
be reported separately only and not included in the cost-
effectiveness estimates. A 3% discount rate is to be used to 
capture time preferences effectiveness.
7 .  Non-health effects and costs 
that do not accrue to the health 
budget should be identified where 
relevant to the decision problem. 
All costs and effects should be 
disaggregated, either by sector of 
the economy or by whom they are 
incurred (see also GHCC 4).
Most of the costs incurred to develop and deliver VAWG 
prevention interventions fall under non-health budgets. We 
recommend quantifying and analyzing all these costs. The 
micro-costing approach allows for disaggregation of costs by 
contributing sector, where relevant.
 8.  The cost and effects of the 
intervention on sub-populations 
should be explored and 
implications characterized (see 
also GHCC 5, which also includes 
variation by site/organization).
We recommend analysts collect cost data with sufficient 
variation in geography, size, and platform type to analyze 
how these key cost drivers may affect overall intervention 
cost. The cost-effectiveness analysis should report on pre-
specified sub-populations for trials (i.e., sub-populations listed 
in the trial protocol) and on sub-populations likely to differ 
substantially from the average in terms of costs and/or cost-
effectiveness (also see iDSI Principle 8).
Table A1. (continued)
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Table A1. (continued)
iDSI Statements of Principle
(Adapted with permission from: 
https://www.idsihealth.org/resources/
summary-table/) VAWG Guidelines
 9.  Uncertainty should be 
appropriately characterized (see 
also GHCC 16).
Model and parameter uncertainty is to be addressed with uni- 
and multivariate sensitivity analysis. Monte Carlo simulations 
are to be used to explore precision of the estimates. 
Intervention sustainability is to be investigated based on 
changes in VAWG impact post-exposure to the intervention, 
where the data are available.
10.  The impact of implementing the 
intervention on health budget and 
on other constraints should be 
clearly and separately identified.
Where interventions are successful and likely to be funded, 
budget impact analysis will be conducted for the national 
or local government. Where clients or target populations 
incur costs to access services, we also recommend a societal 
perspective. A societal perspective should also include 
productivity losses due to VAWG and may include costs to 
non-health sectors such as criminal justice or social services.
11.  An economic evaluation should 
explore the equity implications of 
implementing the intervention.
Analysts should explore potential inequalities in access 
and ability to benefit connected to baseline health or 
socioeconomic characteristics, or levels of VAWG exposure 
via, for example, subgroup analyses.
Note. This table contains a summary of our guidance for conducting economic evaluations of VAWG 
prevention and women’s empowerment interventions in low- and middle-income countries. The reader is 
encouraged to refer to the main body of the article for in-depth explanations. Our accompanying costing 
guidelines (at https://bit.ly/2vKaGZZ), the iDSI Reference Case and the GHCC Reference Case websites 
offer further insights into the concepts referred in the table. iDSI = International Decision Support 
Initiative; VAWG = violence against women and girls; GHCC = Global Health Costing Consortium;  
PICO = Population Intervention Comparator Outcome; DALYs = disability-adjusted life years.
Table A2. Additional GHCC Reference Case Recommendations (Costs) and 
VAWG Guidelines.
GHCC Recommendations
(Adapted with permission from: https://
ghcosting.org/pages/standards/reference_case) VAWG Guidelines
2.  The perspective of the cost estimation 
should be defined.
We recommend transparency in perspective. The analyst 
should declare if the economic evaluation takes the 
perspective of the NGO provider or the health sector.
3.  The type of unit cost estimated should 
be defined in terms of economic versus 
financial, real-world versus normative 
best practice, and full versus incremental 
cost, and whether the cost is net of 
future cost savings. The type of cost 
should be justified relevant to purpose.
We recommend the estimation of real-world full 
economic costs of developing and delivering the 
intervention and, where relevant, its “usual care” 
comparator. We do not recommend computing 
future cost savings, due to the uncertainty surrounding 
estimates of costs to society of VAWG.
4.  The “units” in the unit costs for 
strategies, services, and interventions 
should be defined, relevant for the costing 
purpose, and generalizable.
We identify units relevant to a range of programs and 
settings (see Table 3). We recommend unit costs 
relevant to the type of program and setting be 
estimated and reported.
(continued)
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GHCC Recommendations
(Adapted with permission from: https://
ghcosting.org/pages/standards/reference_case) VAWG Guidelines
 6.  The scope of the inputs to include in 
the cost estimation should be defined 
and justified relevant to purpose. Where 
inputs are excluded for pragmatic 
reasons, these should be reported.
To identify all relevant inputs, and exclude all inputs that 
are not relevant, we recommend analysts compile 
a detailed description of inputs for the intervention 
development, adaptation, and implementation phases. 
For a template, see the intervention description 
workbook attached to our guidelines, downloadable 
from the project resources pages of the What Works? 
Program: https://bit.ly/2vKaGZZ
 7.  The methods for estimating the 
quantities of inputs should be described, 
including methods, data sources, and 
criteria for allocating shared costs, and 
the exclusion of research costs.
Studies should implement a bottom-up approach based 
on micro-costing for direct costs. For overhead and 
support costs, a top-down approach based on micro-
costing is deemed acceptable, if micro-costs are not 
available (for definitions, see our guidelines at https://
bit.ly/2vKaGZZ).
 8.  The sampling frame, method, and size 
should be determined by the precision 
demanded by the costing purpose and 
designed to minimize bias.
VAWG prevention efforts often rely on high numbers 
of staff and volunteers. We therefore recommend 
sampling a subset of sites to capture variation in service 
delivery. This ensures the sample is representative 
of the different settings where the intervention is 
delivered and that the data can be used in modeling 
scale-up analyses.
 9.  The selection of the data source and 
methods for estimating “units” for unit 
costs should be described, with potential 
biases reported in the study limitations.
We recommend identifying relevant units for unit costs 
based on a review of the literature in the intervention’s 
specific field, in the first instance. However, where 
publications are scarce, we also recommend 
interviewing implementation managers and developers 
to identify useful units not included in the literature.
10.  Consideration should be given to the 
timing of data collection to minimize 
recall bias and, where relevant, the 
impact of seasonality and other 
differences over time.
We advise prospective data collection. However, where 
this is not feasible due to project timetable constraints, 
we advise that retrospective data collection takes place 
as soon as possible after end of delivery.
11.  The sources for price data should reflect 
the price relevant to purpose and be 
described for each input in a way that 
allows for adjustment across settings.
We recommend analysts report the sources for each 
price used.
12.  Capital costs should be appropriately 
amortized or depreciated to reflect the 
expected life of capital inputs
Capital costs are first expressed in real prices at the base 
year and then annuitized based on their expected life 
using standard tables (see, for example, Drummond 
et al., 2014).
13.  Where relevant, appropriate discount, 
inflation, and currency conversion rates 
should be used and clearly stated.
Base case: We recommend the use of a standard 3% 
discount rate, the use of the GDP deflator as an 
inflation index, and the use of market exchange 
rates to convert currencies. Sensitivity analyses: Local 
discount rates, market exchange rates adjusted for 
PPA rates to take differences in price levels into 
account; “VAWG”-specific PPP and substitution of 
local prices with prices from other localities, where 
comparisons are being made.
Table A2. (continued)
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GHCC Recommendations
(Adapted with permission from: https://
ghcosting.org/pages/standards/reference_case) VAWG Guidelines
14.  The use and source of shadow prices, 
for goods where no market price exists, 
and for the opportunity cost of time 
should be reported.
Base case: We recommend the use of replacement 
costs as a pragmatic option in the absence of market 
prices. Data sources should be clearly identified 
and documented in the tools. Sensitivity analysis: 
The opportunity cost of using specific resources is 
computed, and sources reported.
15.  Variation in the cost of the intervention 
by site size/organization, sub-
populations, or by other drivers of 
heterogeneity should be explored and 
reported.
We recommend analysts collect cost data with sufficient 
variation in geography, size, and platform type to 
analyze how these key cost drivers may affect overall 
intervention cost. The cost-effectiveness analysis 
should report on pre-specified sub-populations 
(for trials), and on sub-populations likely to differ 
substantially from the average in terms of costs and/or 
cost-effectiveness (also see iDSI Principle 8).
Note. This table contains a summary of our guidance for conducting economic evaluations of VAWG 
prevention and women’s empowerment interventions in low- and middle-income countries. The reader is 
encouraged to refer to the main body of the article for in-depth explanations. Our accompanying costing 
guidelines (at https://bit.ly/2vKaGZZ), the iDSI Reference Case and the GHCC Reference Case websites 
offer further insights into the concepts referred in table. GHCC = Global Health Costing Consortium; 
VAWG = violence against women and girls; NGO = nongovernmental organization; GDP = gross domestic 
product; PPA = purchasing power adjusted; PPP = purchasing power parity; iDSI = International Decision 
Support Initiative.
Table A2. (continued)
Table A3. Sensitivity Analyses.
Source of Uncertainty Alternative Values/Scenarios Recommended Sensitivity Analysis
Methodological
 Discount factor Local/national level discount 
factor; differential discount 
factors for costs and 
outcomes
Deterministic uni- and multivariate
 PPP World Bank PPPs, and VAWG 
prevention-specific PPP, 
where interventions are 
sufficiently similar
Deterministic uni- and multivariate
 Time horizon Lifetime Probabilistic
 Perspective Societal Probabilistic
 Valuing the time of free 
human resources
Types of time forgone If the volunteer is unemployed, analysts 
will use the gross wage in the 
volunteer’s potential occupational 
group; the individual’s gross wage, 
if he or she works part-time and 
volunteers the rest of the work time; 
the individual’s net wage if he or she is 
employed but volunteers his or her free 
time (Posnett & Jan, 1996).
(continued)
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Source of Uncertainty Alternative Values/Scenarios Recommended Sensitivity Analysis
Parameter
 VAWG exposure Vary based on evidence; expert 
opinion and best- or worst-
case scenario
Deterministic uni- and multivariate; 
threshold analysis and probabilistic 
sensitivity analysis
 DALY impact
 Cost of treatment
 Precision of parameter 
estimates (stochastic 
uncertainty)
Monte Carlo simulations
Subgroups with heterogeneous cost-effectiveness
 Age Multivariable sensitivity analysis to test 
robustness. Could include analysis 
where robustness of results is tested 
across the entire distribution (e.g., 
quintile regressions).
 Gender  
 Baseline exposure to 
VAWG
 
 VAWG risk factors  
 Alcohol consumption
 Mental health issues
 Small children
 Pregnancy
 Age at sexual debut
 Age at marriage
 Employment status
 
 Urbanicity  
 Site accessibility  
Note. PPP = purchasing power parity; VAWG = violence against women and girls; DALY = disability-
adjusted life year.
Table A3. (continued)
Author Contributions
G.F. drafted the manuscript and devised and adapted the methodology under A.V.’s 
supervision; A.V. edited the first draft of the manuscript; S.T.-R. provided feedback 
on the methodology; and S.T.-R., C.W., R.J., and C.M.-I. provided feedback on drafts 
of the paper. All authors reviewed and approved the final version of the manuscript.
Declaration of Conflicting Interests
The author(s) declared the following potential conflicts of interest with respect to the 
research, authorship, and/or publication of this article: C.W. is the Chief Scientific 
Adviser at the Department for International Development (UKAid). This work was 
conducted as part of her academic role as professor in epidemiology at the London 
School of Hygiene & Tropical Medicine.
Funding
The author(s) disclosed receipt of the following financial support for the research, 
authorship, and/or publication of this article: G.F., S.T.-R., R.J., and A.V. received 
U.K. aid funding from the U.K. government, via the What Works to Prevent Violence 
24 Journal of Interpersonal Violence 00(0)
Against Women and Girls Global Program. The views expressed do not necessarily 
reflect the government’s official policies. The funds were managed by the South 
African Medical Research Council.
Ethics and Dissemination
Ethical approval for the implementation of this methodology at five sites on the 
African continent was obtained from the London School of Hygiene and Political 
Science (12204), and as an amendment to existing ethics approvals at the following 
institutions: Johns Hopkins University (00006534), Kenya Medical Research Institute 
(KEMRI; KEMRI/RES/7/3/1), South African Medical Research Council (EC006-
2/2015 [South Africa], EC031-9/2015 [Ghana], EC033-10/2015 [Rwanda]), Stanford 
University (4947), the Rwanda National Ethics Committee (RNEC; 40/RNEC/2015), 
the University of Ghana (006/15-16), the University of KwaZulu-Natal (BFC043/15), 
and the University of Zambia Biomedical Research Ethics Committee (UNZAREC; 
004-11-15).
ORCID iD
Giulia Ferrari  https://orcid.org/0000-0002-1670-4905
Notes
1. They are found at this link: https://bit.ly/2vKaGZZ
2. The economic cost of a resource is determined by the price it commands in its 
next best use. This is the concept of “opportunity cost,” on which the economic 
cost is based. One way of determining this cost is to look at market prices for 
the resource used or for similar resources (shadow prices). For example, if the 
implementer has free access to a community hall to deliver the intervention, the 
hall’s economic cost is equal to its rental price when used for other purposes, 
because its use for the intervention prevents it from being used for these other 
purposes.
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